These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38643056)

  • 1. Automated liver volumetry and hepatic steatosis quantification with magnetic resonance imaging proton density fat fraction.
    Chang YC; Yen KC; Liang PC; Ho MC; Ho CM; Hsiao CY; Hsiao CH; Lu CH; Wu CH
    J Formos Med Assoc; 2024 Apr; ():. PubMed ID: 38643056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of Multi-echo Dixon Sequence in Quantification of Hepatic Steatosis.
    Yurdaisik I; Nurili F
    Cureus; 2020 Feb; 12(2):e7103. PubMed ID: 32231898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Accuracy and Clinical Relevance of the Multi-echo Dixon Technique for Evaluating Changes to Hepatic Steatosis in Patients with Non-alcoholic Fatty Liver Disease Treated with Formulated Food.
    Yang Y; Xu K; Chen X; Ding J; Shi J; Li J
    Magn Reson Med Sci; 2023 Apr; 22(2):263-271. PubMed ID: 35676065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing hepatic steatosis by magnetic resonance in potential living liver donors.
    Kuru Öz D; Ellik Z; Gürsoy Çoruh A; Adıgüzel M; Gümüşsoy M; Kiremitci S; Kırımker OE; Gökcan H; Elhan AH; Balcı D; Savaş B; Erden A; İdilman R
    Diagn Interv Radiol; 2024 Nov; 30(6):351-356. PubMed ID: 38737404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters.
    Yoo J; Joo I; Jeon SK; Park J; Yoon SH
    Eur Radiol; 2024 Sep; 34(9):6205-6213. PubMed ID: 38393403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated hepatic steatosis assessment on dual-energy CT-derived virtual non-contrast images through fully-automated 3D organ segmentation.
    Jeon SK; Joo I; Park J; Yoo J
    Radiol Med; 2024 Jul; 129(7):967-976. PubMed ID: 38869829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of magnetic resonance imaging proton density fat fraction (MRI-PDFF), magnetic resonance spectroscopy (MRS), and two different histopathologic methods (artificial intelligence
    Kim JW; Lee CH; Yang Z; Kim BH; Lee YS; Kim KA
    Quant Imaging Med Surg; 2022 Nov; 12(11):5251-5262. PubMed ID: 36330193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
    PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy.
    Krishan S; Jain D; Bathina Y; Kale A; Saraf N; Saigal S; Choudhary N; Baijal SS; Soin A
    Clin Radiol; 2016 Jan; 71(1):58-63. PubMed ID: 26555703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of volumetric thigh and paravertebral muscle fat content: comparison of quantitative Dixon (Q-Dixon) magnetic resonance imaging (MRI) with high-speed T
    Zhang W; Fu C; Yan D; Yuan Y; Zhang W; Gu D; Wu Y; Zhang D; Wang L; Cheng X
    Quant Imaging Med Surg; 2024 Jul; 14(7):4490-4505. PubMed ID: 39022270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of an automated screening Dixon technique for quantifying hepatic steatosis in living liver donors.
    Song S; Kim H; Choi JI; Kim DH; Kim B; Lee H; Lee J
    Abdom Radiol (NY); 2024 Feb; 49(2):406-413. PubMed ID: 37801142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology.
    Kang BK; Kim M; Song SY; Jun DW; Jang K
    Br J Radiol; 2018 Sep; 91(1089):20170378. PubMed ID: 29022777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy.
    Zhan C; Olsen S; Zhang HC; Kannengiesser S; Chandarana H; Shanbhogue KP
    Abdom Radiol (NY); 2019 Sep; 44(9):3040-3048. PubMed ID: 31286208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population.
    Hetterich H; Bayerl C; Peters A; Heier M; Linkohr B; Meisinger C; Auweter S; Kannengießer SA; Kramer H; Ertl-Wagner B; Bamberg F
    Eur Radiol; 2016 Jun; 26(6):1895-904. PubMed ID: 26340812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutoff Values for Diagnosing Hepatic Steatosis Using Contemporary MRI-Proton Density Fat Fraction Measuring Methods.
    Park S; Kwon JH; Kim SY; Kang JH; Chung JI; Jang JK; Jang HY; Shim JH; Lee SS; Kim KW; Song GW
    Korean J Radiol; 2022 Dec; 23(12):1260-1268. PubMed ID: 36447414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Learning for Inference of Hepatic Proton Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI: Retrospective Analysis of Population-Based Trial Data.
    Wang K; Cunha GM; Hasenstab K; Henderson WC; Middleton MS; Cole SA; Umans JG; Ali T; Hsiao A; Sirlin CB
    AJR Am J Roentgenol; 2023 Nov; 221(5):620-631. PubMed ID: 37466189
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
    Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
    Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.